IL6 and COVID-19: Indeed, studies have demonstrated that proinflammatory cytokines and chemokines, such as tumor necrosis factor α (TNF‐α), IL‐1β, IL‐6, and granulocyte‐colony stimulating factor are significantly upregulated in COVID‐19 patients.92, 93, 94